Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 3 1Phase 1/2 1

Status

Recruiting 3Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 8Gastrointestinal 7Breast 7Other hematologic neoplasm 6Thoracic 4Other solid neoplasm 3Head & Neck 3Dermatologic 3Tumor-Agnostic 2Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 5Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Bilateral Breast Carcinoma 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Letrozole 34Fulvestrant 31Specimen Handling 29ribociclib 22pembrolizumab 22Paclitaxel 21Magnetic Resonance Spectroscopy 20palbociclib 19Trastuzumab 19Anastrozole 19Carboplatin 18Capecitabine 18exemestane 17abemaciclib 16Biopsy 16Tamoxifen 15pertuzumab 14trastuzumab deruxtecan 12Cyclophosphamide 10Taxes 9Radiotherapy 8Goserelin 8Docetaxel 8giredestrant 7Standard of Care 7130-nm albumin-bound paclitaxel 7inavolisib 6eribulin 6elacestrant 6atezolizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Standard of Care × Breast × 30 days × Clear all
NCT05874297 2026-06-05

ONE

Fred Hutchinson Cancer Center

Phase NA Not yet recruiting
50 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT04567420 2026-06-03

DARE

Criterium, Inc.

Phase 2 Recruiting
70 enrolled
Breast

Breast Neoplasms

NCT05787834 2026-05-29

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

Roswell Park Cancer Institute

Phase NA Recruiting
130 enrolled
BreastHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms

NCT07610499 2026-05-28

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled
Breast

Breast Neoplasms

NCT00877500 2026-05-22

Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
116 enrolled
Breast

Bilateral Breast Carcinoma

NCT06502691 2026-05-19

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

University of Washington

Phase 1/2 Recruiting
22 enrolled
Breast

Breast Neoplasms

NCT07590505 2026-05-15

ULTIMO

Cancer Research Antwerp

Phase 3 Completed
132 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡